Introduction {#j_hukin-2019-0061_s_001}
============

During the menstrual cycle, women are exposed to continuous variations in serum concentrations of several female sex steroid hormones. Fluctuations in the main four female sex hormones, namely, estrogen, progesterone, follicle stimulating hormone, and luteinizing hormone are essential to regulate the patterns of the ovulatory cycle. Fluctuations of these hormones also induce two main phases in a regular/normal menstrual cycle: the follicular phase and the luteal phase. Both of these phases are separated by a shorter-time ovulation period in the middle of the cycle. The follicular phase is normally divided into two sub-phases: (a) the early follicular phase (EFP), which is characterized by low serum concentration of both estrogen and progesterone; and (b) the late follicular phase (LFP) where maximal estrogen concentration coincides with low progesterone levels and ends with an upsurge of luteinizing hormone that precedes the ovulation. The luteal phase begins once the luteinizing hormone has returned to basal levels and is characterized by high concentrations of both estrogen and progesterone. Peak values of estrogen and progesterone are generally observed within the mid-term of the luteal phase (MLP).

Estrogen is a hormone with a purported anabolic function, while progesterone has been related to catabolic pathways ([@j_hukin-2019-0061_ref_006]). Given these differences in hormone functions, it has been speculated that skeletal muscle performance might vary with alterations in hormone production during different phases of the menstrual cycle. However, the current body of literature does not provide clear answers on this topic ([@j_hukin-2019-0061_ref_001]; [@j_hukin-2019-0061_ref_011]; [@j_hukin-2019-0061_ref_016]). [@j_hukin-2019-0061_ref_019] reported an 11% increase in quadriceps and handgrip maximum voluntary isometric force in the ovulation period which coincided with the LFP. Likewise, [@j_hukin-2019-0061_ref_001] reported that isometric strength performance peaked during the ovulation phase. These results suggest a potential association between the upsurge of the luteinizing hormone and enhanced muscle strength. However, other studies have not supported these findings as no changes in muscle strength across different phases of the menstrual cycle were found ([@j_hukin-2019-0061_ref_011]; [@j_hukin-2019-0061_ref_012]; [@j_hukin-2019-0061_ref_016]). For example, [@j_hukin-2019-0061_ref_012] and [@j_hukin-2019-0061_ref_014] reported no differences in concentric and eccentric muscle torque between the menstrual, follicular, and luteal phases and similar findings were reported by others ([@j_hukin-2019-0061_ref_011]; [@j_hukin-2019-0061_ref_016]).

The equivocal evidence might be due to the use of different methods to estimate the phases of the menstrual cycle and the use of different muscle strength performance tests. One possible limitation of the current evidence is that most studies measured maximal/peak values of muscle strength. However, in the practical context, the expression of maximal strength rarely occurs, especially if we consider that resistance training (RT) is commonly performed with submaximal loads (e.g., 80% of one repetition maximum \[1RM\]). Also, previous studies used laboratory-based isometric and isokinetic tests of strength. However, in recent years, practitioners have started using velocity data for prediction of and monitoring changes in maximal strength. To the best of our knowledge, there are no studies that explored the effects of different phases of the menstrual cycle on muscle strength and power performance as assessed using barbell velocity measures across low, moderate, and high loading zones. Therefore, the aim of this study was to investigate muscle performance variations across three phases of the menstrual cycle (ELP, LFP, and MLP) by measuring velocity, power and force output in the Smith machine half-squat exercise with loads equivalent to 20, 40, 60 and 80% of 1RM.

Methods {#j_hukin-2019-0061_s_002}
=======

Participants {#j_hukin-2019-0061_s_002_s_001}
------------

Thirteen female triathletes volunteered to participate in this study (age = 31.1 ± 5.5 yr; body mass = 58.6 ± 7.8 kg; body height = 1.66 ± 0.06 m; body fat percentage = 14.5 ± 6.5%). All participants had a regular menstrual cycle for the four months previous to the experiment (27 ± 2 days, range = 24-31 days) and were considered as eumenorrheic. Participants were not using any form of hormonal contraception for at least the six months previous to the experiment. Furthermore, all participants were free from any type of menstrual disorders (e.g., dysmenorrhea, amenorrhea, or heavy symptoms associated with pre-menstrual syndrome), had no musculoskeletal injuries in the three months previous to the investigation and were not taking drugs or dietary supplements during the duration of the experiment. Participants were included if they had at least six months of RT experience (16 ± 8 months of experience in this sample), and were familiar with the half-squat exercise. During the experimental period, participants were encouraged to maintain their usual training routines. Two weeks before the onset of the experiment protocol, informed consent was obtained from each participant. The experimental protocol was approved by the Human Ethics Committee of the Camilo José Cela University, in accordance with the latest update of the Declaration of Helsinki (2013).

Study design {#j_hukin-2019-0061_s_002_s_002}
------------

In this study, we aimed to investigate the differences in muscle performance in the half-squat exercise during three different phases of the menstrual cycle. The three phases of the menstrual cycle were EFP, LFP, and MLP, because they represent main events occurring during the menstrual cycle (i.e., menses, pre-ovulation, and peak progesterone concentration, respectively; [@j_hukin-2019-0061_ref_014]). To explore this topic, participants performed one repetition (REP) of the Smith machine half-squat exercise at maximal velocity with loads amounting to 20, 40, 60 and 80% of their respective 1RM ([@j_hukin-2019-0061_ref_004]). This assessment was performed in each menstrual cycle phase ([Figure 1](#j_hukin-2019-0061_fig_001){ref-type="fig"}). The order of the first menstrual cycle phase was randomized for each participant and counterbalanced (four started in the EFP, four started in the LFP and the remaining five started in the MLP). The day before each trial, participants were instructed only to perform low-intensity training and maintain their usual diet/fluid intake routine.

![Timeline of the testing protocol for a participant with a menstrual cycle of 28 days.](hukin-68-123-g001){#j_hukin-2019-0061_fig_001}

Experimental procedures {#j_hukin-2019-0061_s_002_s_003}
-----------------------

Two weeks before the onset of the experiment, participants performed two familiarization sessions with the testing protocol in order to minimize any learning effects during the experiment. One week before the experiment, a 1RM test was performed to standardize the loads in the subsequent experimental sessions. The 1 RM test was performed on a Smith Machine (Technogym, Barcelona, Spain) in which 2 vertical guides regulate the barbell movement. Participants were instructed to perform a countermovement to $90^{\underline{{}^{\circ}}}$of knee flexion until touching a bench and ascend back to an upright position without lifting the toes off the ground. The eccentric phase of the squat was performed in a controlled manner and participants were informed that it should be completed in \~2 s. After 1 s of maintained knee flexion, the concentric phase of the exercise was completed as fast as possible (2/1/X; [@j_hukin-2019-0061_ref_026]).

Participants commenced the 1RM assessment with sets of increasing loads estimated to be \~20% 1RM (3-REPs), \~40% 1RM (3-REPs), \~60% 1RM (3-REPs), \~80% 1RM (1-REP), and \~90% 1RM (1-REP; [@j_hukin-2019-0061_ref_002]. This was then followed by the first 1RM attempt with a maximum of five 1RM attempts permitted. After a successful 1RM attempt, the barbell load was increased, in consultation with the participant, between 0.5 and 2.5 kg. The last successful lift with a correct technique was classified as the 1RM load. Two minute passive rest intervals were allocated between all warm-up sets and three minutes of recovery between the 1RM attempts.

Afterwards, participants performed three identical experimental trials starting with the phase randomly assigned. All three trials were performed in a laboratory, in the morning (between 9 and 11 AM) and under similar environmental conditions $(22 - 23^{\underline{{}^{\circ}}}\text{C}$and 60% humidity; OH1001, OH Haus, Spain). Participants arrived at the laboratory in a fed state (\~3 hours after their last meal). In each experimental trial, the participant was nude-weighed after voiding (Tanita BF 350, Tanita Corporation, Tokyo, Japan). After that, they performed a standardized 15-min warm-up protocol (5-min pedaling on a cycle ergometer at 60 W, followed by mobility exercises and bodyweight half-squats; [@j_hukin-2019-0061_ref_003]). After warming up, participants performed two attempts of the half-squat exercise at maximal velocity with loads that represented 20, 40, 60 and 80% of their 1RM. All attempts were performed on the same Smith machine that was used for the 1RM assessment. Performance data were measured only during the concentric phase of the movement. Two minute passive rest intervals were allocated between the attempts with the same load and three minutes between different loads. The complete range of motion consisted of lowering the body by bending the knees to a $90^{\underline{{}^{\circ}}}$angle until touching a bench. Execution technique and motivation were standardized and monitored by 2 experienced researchers for greater safety of the participants and reliability of the experimental conditions. In each attempt, barbell displacement (measured in cm), mean and peak velocity (MV and PV, respectively; measured in m/s), mean and peak power output (MP and PP; respectively; measured in W) as well as mean and peak force (MF and PF, respectively, measured in N) were measured in the concentric phase of the movement using a rotatory encoder (Isocontrol, EV-Pro, Spain). The rotatory encoder consists of a velocity sensor connected to the bar by a cable and it records the vertical velocity of the bar during the displacement with a frequency of 500 Hz. This encoder is a reliable system for measuring bar velocity during half-squat exercise. Software associated with the encoder calculated MP and PP from the product of force and bar velocity. This device has been reliably used in previous investigations to assess the effects of caffeine intake on muscle force, velocity and power output ([@j_hukin-2019-0061_ref_007]). The attempt with the highest barbell displacement velocity in each load was used for further statistical analysis. The 1RM was estimated in all phases to ensure that 1RM remained unchanged during the experiment ([@j_hukin-2019-0061_ref_004]).

Determination of the menstrual phase {#j_hukin-2019-0061_s_002_s_004}
------------------------------------

The duration of the menstrual cycle and the onset of each phase were determined using: (a) period tracker application; (b) measurement of tympanic temperature and body mass changes; and (c) assessment of urinary peak of the luteinizing hormone, following established recommendations ([@j_hukin-2019-0061_ref_001]; [@j_hukin-2019-0061_ref_024]; [@j_hukin-2019-0061_ref_023]). The duration of the menstrual cycle was recorded for a minimum of 4 months for a valid characterization. This information was obtained using a mobile application (Mycalendar®, Period-tracker, US) together with a menstruation diary, which included the date of menses, length of menses, and discomfort in the days preceding menses and during the menses. During the familiarization period, participants were informed on how to measure their own basal tympanic temperature and body mass. A digital thermometer (model HDT8208C, Nursal Ear Thermometer, China) and a digital scale (BT200, Daga, Spain) were used for this aim and tympanic temperature and body mass were measured and recorded every morning immediately after waking up (tympanic temperature; EFP: 36.34 ± $0.42^{\underline{{}^{\circ}}};$LFP: 36.43 ± $0.62^{\underline{{}^{\circ}}};$MLP: 36.42 ± $0.47^{\underline{{}^{\circ}}},$body mass; EFP: 58.86 ± 9.28 kg; LFP: 58.89 ± 9.14 kg; MLP: 59.03 ± 9.11 kg). Participants collected these data for one complete menstrual cycle, starting with the phase randomly allocated. In addition, participants were supplied with 7 reactive test strips (One Step Ovulation LH Test Strip; CVS Corporation, US) to assess increases in luteinizing hormone in the first-morning urine sample. With this information, the beginning of the EFP was indicated by the onset of menses, the LFP was indicated by a positive test for urinary luteinizing hormone ([@j_hukin-2019-0061_ref_014]) and the MLP was determined between the 70 and 75% of the individual menstrual cycle length (i.e., from the 20^th^ to the 22^nd^ day of the menstrual cycle for a regular cycle of 28 days) ([@j_hukin-2019-0061_ref_014]). All these protocols helped align the participants' cycle and therefore, despite different cycle lengths, participants performed testing in the same cycle phases.

Statistical analysis {#j_hukin-2019-0061_s_002_s_005}
--------------------

Data analysis was conducted using the statistical software package SPSS v.20 (SPSS Inc., Chicago, IL, USA). Descriptive statistics included means and standard deviations for all variables. A Shapiro--Wilk test was used to test the data for normality of distribution (*p* \> 0.05). The differences in the performance data between the three phases of the menstrual cycle were analyzed using one-way repeated-measures analysis of variance (ANOVA). The statistical threshold was set at *p* \< 0.05. Additionally, effect sizes (ES) were calculated in all pairwise comparisons to allow a magnitude-based inference approach. Specifically, the effect-size statistic ± 90% confidence interval (CI) was used on log-transformed data to reduce bias due to non-uniformity of error. The smallest significant standardized effect threshold was set as 0.2, and a qualitative descriptor was included to represent the likelihood of exceeding this threshold. Ranges of likelihood were: \<1% indicated almost certainly no chances of change; 1 to 5% indicated very unlikely; 5 to 25% indicated unlikely; 25 to 75% indicated possible; 75 to 95% indicated likely; 95 to 99% indicated very likely; \>99% indicated most likely. Differences were rated as unclear when likelihood exceeded \>5% in both positive/negative directions. ESs were interpreted according to the following ranges: \<0.2, trivial; 0.2--0.6, small; 0.6--1.2, moderate; 1.2-- 2.0, large; 2.0--4.0, very large; and \>4.0, extremely large ([@j_hukin-2019-0061_ref_013]).

Results {#j_hukin-2019-0061_s_003}
=======

The estimated values of 1RM in the half-squat exercise remained unchanged during the three phases of the menstrual cycle: EFP: 97.0 ± 23.2 kg; LFP: 98.5 ± 18.1 kg; MLP: 98.1 ± 22.2 kg (*p* \> 0.05). One-way ANOVA did not reveal statistically significant differences between the menstrual cycle phases in mean/peak force (*p* \> 0.05; [Figure 2](#j_hukin-2019-0061_fig_002){ref-type="fig"}). At 20% 1RM, MF was possibly lower in the MLP (213.8 ± 68.7 N) than in the LFP (217.5 ± 57.1 N; ES: 0.2 ± 0.3; chance% as positive/trivial/negative = 2/45/53%). At 60% 1RM, MF was possibly greater during the EFP (539.1 ± 107.3 N) compared to the MLP (515.4 ± 115.5 N; ES: 0.3 ± 0.5; 5/35/60%). At 80% 1RM, MF was possibly lower in the MLP (656.2 ± 137.8 N) than the EFP (677.0 ± 140.7 N; ES: 0.2 ± 0.3; 2/59/38%) and the LFP (680.8 ± 124.8 N; ES: 0.2 ± 0.3; 3/56/41%). At 60% 1RM, PF was possibly greater in the EFP (614.6 ± 121.6 N) in comparison with the MLP (599.9 ±150.8 N; ES: 0.2 ± 0.2; 3/31/66). At 80% 1RM, PF was possibly greater in the LFP (803.7 ± 168.7 N) compared to the EFP (792.2 ± 170.4 N; ES: 0.2 ± 0.2; 42/57/0) and the MLP (776.6 ± 172.6 N; ES: 0.2 ± 0.4; 5/47/48).

![Mean (upper panel) and peak force (lower panel) during the concentric phase of Smith machine half-squat exercise at increasing intensity (20, 40, 60 and 80% of 1RM) in each phase of the menstrual cycle. Each symbol is the mean ± standard deviation.](hukin-68-123-g002){#j_hukin-2019-0061_fig_002}

One-way ANOVA did not reveal statistically significant differences between the three phases of the menstrual cycle in mean/peak velocity ([Figure 3](#j_hukin-2019-0061_fig_003){ref-type="fig"}). At 20% 1RM, MV was possibly lower in the MLP (0.7 ± 0.1 m/s) than the EFP (0.72 ± 0.10 m/s; ES: 0.2 ± 0.4; 4/44/51%) and the LFP (0.7 ± 0.1 m/s; ES: 0.4 ± 0.4; 2/23/75%). In addition, at 60% 1RM, MV was possibly greater during the EFP (0.56 ± 0.07 m/s) compared to the MLP (0.5 ± 0.1 m/s; ES: 0.3 ± 0.4; 2/34/64%) and the LFP (0.5 ± 0.1 m/s; ES: 0.2 ± 0.4; 3/42/55%). At 40% 1RM, PV was possibly greater in the MLP (1.3 ± 0.2 m/s) compared to the LFP (1.2 ± 0.2 m/s; ES: 0.3 ± 0.3; 65/34/1).

![Mean (upper panel) and peak velocity (lower panel) of the barbell during the concentric phase of Smith machine half-squat exercise at increasing intensity (20, 40, 60 and 80% of 1RM) in each phase of the menstrual cycle. Each symbol is the mean ± standard deviation.](hukin-68-123-g003){#j_hukin-2019-0061_fig_003}

One-way ANOVA did not reveal statistically significant differences between the three phases of the menstrual cycle phases in mean/peak muscle power ([Figure 4](#j_hukin-2019-0061_fig_004){ref-type="fig"}). At 20% 1RM, MP was possibly greater in the MLP (162.8 ± 60.6 W) compared to the LFP (155.8 ± 49.2 W; ES: 0.2 ± 0.4; 3/40/57); at 40% 1RM, MP was most likely greater also in the MLP (242.6 ± 68.6 W) compared to the EFP (159.9 ± 66.7 W; ES: 0.8 ± 0.3; 100/0/0); at 60% 1RM, MP was possibly greater in the EFP (299.0 ± 70.34 N) compared to the MLP (283.8 ± 84.4 W; ES: 0.3 ± 0.4; 4/28/68). PP was most possibly greater in the MLP (462.0 ± 151.8 W) than the LFP (450.6 ± 150.3 W; ES: 0.2 ± 0.2; 36/63/1) at 40% 1RM.

![Mean (upper panel) and peak power output (lower panel) during the concentric phase of Smith machine half-squat exercise at increasing intensity (20, 40, 60 and 80 of 1RM) in each phase of the menstrual cycle. Each symbol is the mean ± standard deviation.](hukin-68-123-g004){#j_hukin-2019-0061_fig_004}

Discussion {#j_hukin-2019-0061_s_004}
==========

The aim of this study was to investigate muscle force (N), velocity (m/s) and power output (W) variations across three different phases of the menstrual cycle in resistance exercise performed with loads equivalent to 20, 40 60 and 80% of 1RM. Overall, the results of this investigation indicate that there were no systematic variations in muscle performance during the menstrual cycle, as measured in a wide range of loads (from 20 to 80% of 1RM). The lack of an effect of the menstrual cycle on muscle performance was evident for mean and peak values of force, velocity, and power output which therefore suggests that muscle strength and power performance of eumenorrheic women are not affected by different phases of the menstrual cycle.

Our findings are consistent with outcomes of previous studies ([@j_hukin-2019-0061_ref_011]; [@j_hukin-2019-0061_ref_015]; [@j_hukin-2019-0061_ref_016]; [@j_hukin-2019-0061_ref_017]) in which researchers reported no differences in maximal force among menstrual cycle phases. However, muscle strength tests most commonly used in previous studies included the handgrip test and isokinetic testing for knee flexors and extensors. Both tests are valid for the measurement of maximal force values, but they do not provide information related to the association of force and velocity in submaximal loading. We selected the half-squat exercise with increasing loads to determine whether the menstrual cycle affected muscle performance in a wide range of low-to-high loads. The variables measured in this study to assess muscle performance (i.e., velocity of the barbell displacement as well as force and power output generated during the concentric phase of the Smith machine half-squat) have a greater practical implication for monitoring training loads than traditional percentage-based loading methods ([@j_hukin-2019-0061_ref_008]). To the best of our knowledge, our study is the first that explored the effects of the menstrual cycle on force and power output using loads of increasing intensity (from 20 to 80% of 1RM).

Given the lack of studies using similar performance tests, the comparison of the results presented herein with other investigations is difficult. Nonetheless, our results support those of previous studies (that used isometric/isokinetic tests) which indicate that different phases of the menstrual cycle do not affect muscle strength.

Studies using transcranial magnetic stimulation ([@j_hukin-2019-0061_ref_021], [@j_hukin-2019-0061_ref_020]) indicate that the LFP (when estradiol reaches peak concentration) is coupled with enhanced cortical excitation, in contrast to the EFP and the luteal phase that are characterized by cortical inhibition ([@j_hukin-2019-0061_ref_021], 1999). This may be important to emphasize given the clear positive association between excitability and muscle strength ([@j_hukin-2019-0061_ref_010]). Therefore, a logical hypothesis here is that muscle strength should be increased during the LFP due to the increase in excitation and reduced in the EFP due to cortical inhibition. However, the results obtained in the present study do not support this notion as force production was comparable in all menstrual cycle phases. The results did not show any statistically significant differences in MF and PF, velocity, nor power output. In addition, the magnitude-based inference analysis showed small ES magnitudes. Based on these findings, it seems that the mean and peak force, velocity and power output performance in the Smith machine half-squat for eumenorrheic women is not affected by different phases of the menstrual cycle. However, these results might not be applicable to athletes with dysmenorrhea and premenstrual syndrome ([@j_hukin-2019-0061_ref_005]) and further investigation is warranted on women with irregular/abnormal menstrual cycles.

While we did not find any significant differences in exercise performance in our sample, these results do not dispute the notion that hormone fluctuations during the menstrual cycle may influence hallmark adaptations to long-term RT such as increased strength and muscle hypertrophy. In fact, this speculation has been confirmed by two previous investigations. In these studies, changes in maximum isometric muscle force and muscle diameters ([@j_hukin-2019-0061_ref_022]) were greater when the frequency of RT was high in the follicular phase and low in the luteal phase as compared to training with a low frequency in the follicular phase and high in the luteal phase. These results are likely based on the anabolic properties of estrogen, suggesting that a positive anabolic hormone milieu coupled with more often increases in muscle protein synthesis (via increased training frequency) favor gains in muscle mass during the late follicular phase ([@j_hukin-2019-0061_ref_022]; [@j_hukin-2019-0061_ref_025]). Considering results of these two investigations, together with the findings of our study, it seems the improved RT adaptations observed in those two studies are the result of the anabolic effect of estrogen ([@j_hukin-2019-0061_ref_009]) rather than an improved muscle capacity for training in the follicular phase.

There are several limitations to this study that should be mentioned and discussed. Firstly, to determine the onset of the menstrual cycle phases we used a menstrual period tracker application and measured changes in tympanic temperature and body mass. In addition, we also used luteinizing hormone urine test strips, as previously recommended ([@j_hukin-2019-0061_ref_001]; [@j_hukin-2019-0061_ref_024], 2016). This is a valid methodology and was used in previous studies ([@j_hukin-2019-0061_ref_001]; [@j_hukin-2019-0061_ref_018]), however, there was no measurement of serum female sex hormones to confirm the cycle length and the beginning/end of each phase. Secondly, although the individuals who participated in this study had at least six months of RT experience, they had no experience in velocity-based training. Finally, although none of our participants reported heavy menstrual bleeding, we did not obtain data about the exact amount of blood lost during menstruation. Given that this may be important, future investigations on this topic should consider including this measurement as well.

In conclusion, the results of this study suggest that resistance-trained eumenorrheic females have similar velocity, force, and power performance when exercising with loads equivalent to 20, 40, 60 and 80% of 1RM in the Smith machine half-squat exercise during the different phases of the menstrual cycle.
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